Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206
SHANGHAI - Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that ...
Read more